Recruitment is a key part of Lindus Health's end-to-end model for trial delivery. A combination of the right channels can recruit for any study and massively boost recruitment rate, no matter the indication.
Our recruitment channels are social media, patient advocacy groups, and our Primary Care Network. In this blog post we'll explore how we work with primary care providers to turbocharge recruitment, as well as to help deliver decentralised trials.
Primary care organisations are the first point of contact for most people seeking treatment for a health condition. They are embedded in the communities they serve and have strong relationships with their patients. So it's a shame that most primary care providers aren't set up to take part in even routine research!
Lindus Health has partnered with these organisations to help with just this. We bridge the gap between primary care organisations and trial sponsors to recruit trial participants representative of the population they are after. We also have deep relationships with a number of these organisations to provide trial delivery services directly to their communities.
Lindus Health has a well-developed network in the UK and will be expanding this internationally in 2022 to cover Europe, the US and Asia.
In the UK, we have strategic partners in each of the major cities and so can cover most research sites. In total our network covers over 5 million patients!
There is a nationwide commitment to do more research! “Research is a core part of the NHS...The NHS will do all it can to ensure that patients, from every part of England, are made aware of research that is of particular relevance to them” (NHS Constitution, 2021). But, the typically manual process for taking part in research doesn't make it easy.
Today, Clinical Research Networks provide research opportunities to GP groups but there is a lot of effort required to check their patient lists for eligible participants, and then subsequently communicate with select patients about the trial. Patients are missing out on innovative treatment options, made available through trials, because their doctor isn’t even aware of a certain trial.
That said, the number of UK patients taking part in health research and clinical studies is higher than ever. In 2020/21, in England alone there were nearly 1.4 million research participants (NIHR, 2021). People want to take part in research and primary care should be at the forefront of this!
At Lindus Health we want to work with partners who are committed to our mission, to accelerate research for the next generation of health companies.
Lindus Health and Oto launch remote trial to combat tinnitus
We're excited to announce that we've launched a fully remote clinical study with Oto, a UK-based digital health startup, to combat tinnitus.
Announcing our $18m Series A led by investors Creandum and with participation from Peter Thiel
The funding comes from Spotify-backer Creandum, with participation from PayPal co-founder Peter Thiel and returning investors firstminute, Seedcamp, Hambro Perks, Amino Collective, Page One Ventures and Calm/Storm. Additional investment has been provided by angel investors including Nadav Rosenberg, Kaysan Nikkhah, Trevor Martin, Soraya Darabi, Andrej Steinberg, Tom Krüger and Mithi Thaya.
Why I joined Lindus Health - Anthony Brogno, Director of Clinical Operations
To break the mold of the CRO status quo. To leverage social medial and technology to support research operations. The Lindus Health culture. Hear more from Anthony Brogno, Director of Clinical Operations, on why he joined Lindus Health.